All Stories

  1. The Translational Impact of Plant-Derived Xeno-miRNA miR-168 in Gastrointestinal Cancers and Preneoplastic Conditions
  2. The relative abundance of fecal bacterial species belonging to the Firmicutes and Bacteroidetes phyla is related to plasma levels of bile acids in young adults
  3. Data from EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
  4. Data from EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
  5. Supplementary Fig 18 from EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
  6. Supplementary Fig 18 from EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
  7. Unlocking the bentonite microbial diversity and its implications in selenium bioreduction and biotransformation: Advances in deep geological repositories
  8. Plasma Levels of Omega-3 and Omega-6 Derived Oxylipins Are Associated with Fecal Microbiota Composition in Young Adults
  9. Primers matter: Influence of the primer selection on human fungal detection using high throughput sequencing
  10. Characterization of Maladaptive Processes in Acute, Chronic and Remission Phases of Experimental Colitis in C57BL/6 Mice
  11. Genetic variation inTERTmodifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study
  12. Plasma Levels of Endocannabinoids and Their Analogues Are Related to Specific Fecal Bacterial Genera in Young Adults: Role in Gut Barrier Integrity
  13. Gut microbial similarity in twins is driven by shared environment and aging
  14. Differential Expression of Long Noncoding RNA HOTAIR in Intestinal Metaplasia and Gastric Cancer
  15. Atrophic gastritis and gastric cancer tissue miRNome analysis reveal hsa-miR-129-1 and hsa-miR-196a as potential early diagnostic biomarkers
  16. miRNome Profiling and Functional Analysis Reveal Involvement of hsa-miR-1246 in Colon Adenoma-Carcinoma Transition by Targeting AXIN2 and CFTR
  17. Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease
  18. Profiling of the Bacterial Microbiota along the Murine Alimentary Tract
  19. A Potential Role for Bile Acid Signaling in Celiac Disease-Associated Fatty Liver
  20. The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis
  21. Transcriptome-Wide Analysis of Human Liver Reveals Age-Related Differences in the Expression of Select Functional Gene Clusters and Evidence for a PPP1R10-Governed ‘Aging Cascade’
  22. EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
  23. Gut microbiota profiles and the role of anti‐CdtB and anti‐vinculin antibodies in patients with functional gastrointestinal disorders (FGID)
  24. EGF and BMPs Govern Differentiation and Patterning in Human Gastric Glands
  25. Anti‐TNFα treatment in Crohn’s disease: Impact on hepatic steatosis, gut‐derived hormones and metabolic status
  26. Gender and gut microbiota composition determine hepatic bile acid, metabolic and inflammatory response to a single fast-food meal in healthy adults
  27. Total and Metabolically Active Microbial Community of Aerobic Granular Sludge Systems Operated in Sequential Batch Reactors: Effect of Pharmaceutical Compounds
  28. Inflammatory microRNAs in gastric mucosa are modulated by Helicobacter pylori infection and proton-pump inhibitors but not by aspirin or NSAIDs
  29. Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients—a prospective multicenter study
  30. Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community
  31. Helicobacter pylori induced gastric carcinogenesis - The best molecular model we have?
  32. A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group
  33. Removal of nickel(II) from wastewater using a zeolite-packed anaerobic bioreactor: Bacterial diversity and community structure shifts
  34. Multisystem combined uranium resistance mechanisms and bioremediation potential of Stenotrophomonas bentonitica BII-R7: Transcriptomics and microscopic study
  35. Impact of healthy aging on active bacterial assemblages throughout the gastrointestinal tract
  36. Association of Long Non-Coding RNA Polymorphisms with Gastric Cancer and Atrophic Gastritis
  37. Circulating miR-21-5p level has limited prognostic value in patients with hepatocellular carcinoma and is influenced by renal function
  38. Lipoprotein and Metabolic Profiles Indicate Similar Cardiovascular Risk of Liver Steatosis and NASH
  39. Fusobacterium nucleatum is associated with worse prognosis in Lauren’s diffuse type gastric cancer patients
  40. Contrast-Enhanced Ultrasound Algorithms (CEUS-LIRADS/ESCULAP) for the Noninvasive Diagnosis of Hepatocellular Carcinoma – A Prospective Multicenter DEGUM Study
  41. Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers
  42. First Case of Covid-19 in the United States
  43. Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC
  44. How do international gastric cancer prevention guidelines influence clinical practice globally?
  45. Donated stool for faecal microbiota transplantation is not a drug, but guidance and regulation are needed
  46. miR-20b and miR-451a Are Involved in Gastric Carcinogenesis through the PI3K/AKT/mTOR Signaling Pathway: Data from Gastric Cancer Patients, Cell Lines and Ins-Gas Mouse Model
  47. Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors
  48. Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug
  49. Induction of Secretagogue Independent Gastric Acid Secretion via a Novel Aspirin-Activated Pathway
  50. Review: Gastric cancer—Clinical aspects
  51. Blue Light Imaging and Linked Color Imaging for the Characterization of Mucosal Changes in Chronic Gastritis: A Clinicians View and Brief Technical Report
  52. Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study
  53. Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis
  54. Metaproteomics of fecal samples of Crohn's disease and Ulcerative Colitis
  55. The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent Clostridioides difficile infections in Germany
  56. TLR1 and PRKAA1 Gene Polymorphisms in the Development of Atrophic Gastritis and Gastric Cancer
  57. Identification of long intergenic non-coding RNAs (lincRNAs) deregulated in gastrointestinal stromal tumors (GISTs)
  58. Food‐Derived Xeno‐microRNAs: Influence of Diet and Detectability in Gastrointestinal Tract—Proof‐of‐Principle Study
  59. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives
  60. Modulations in extracellular calcium lead to H+-ATPase-dependent acid secretion: a clarification of PPI failure
  61. Helicobacter Pylori Eradication Therapy is Not Associated with the Onset of Inflammatory Bowel Diseases. A Case-Control Study
  62. Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases
  63. Helicobacter Pylori Serology in Relation to Hepatitis C Virus Infection and IL28B Single Nucleotide Polymorphism
  64. Expression of microRNAs in the ascites of patients with peritoneal carcinomatosis and peritonitis
  65. Influence of laboratory-related and endoscopy-related factors on the assessment of serum pepsinogens and gastrin-17
  66. LINE-1 hypomethylation is not a common event in preneoplastic stages of gastric carcinogenesis
  67. Mo1200 Blue Light Imaging and Linked Color Imaging for Detection and Characterization of Chronic Gastritis
  68. Prevalence of Helicobacter pylori infection among blood donors in Saxony-Anhalt, Germany – a region at intermediate risk for gastric cancer
  69. MiRNA profiling of gastrointestinal stromal tumors by next-generation sequencing
  70. European consensus conference on faecal microbiota transplantation in clinical practice
  71. Activation of Secretagogue Independent Gastric Acid Secretion via Endothelial Nitric Oxide Synthase Stimulation in Rats
  72. Helicobacter pylori vacA genotype is a predominant determinant of immune response to Helicobacter pylori CagA
  73. Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions
  74. Polymorphisms of microRNA target genes IL12B, INSR, CCND1 and IL10 in gastric cancer
  75. Endoscopic peroral jejunal fecal microbiota transplantation
  76. Gastric cancer - clinical and epidemiological aspects
  77. Helicobacter pyloriinfection is associated with a reduced risk of developing eosinophilic oesophagitis
  78. Expression of aurora kinase A correlates with the Wnt‐modulator RACGAP 1 in gastric cancer
  79. Oxyntic gastric atrophy inHelicobacter pylorigastritis is distinct from autoimmune gastritis
  80. MMP2 and MMP7 at the invasive front of gastric cancer are not associated with mTOR expression
  81. Correction: Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer
  82. Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer
  83. Su1828 MiR-155 Expression in Helicobacter pylori Infection, Inflammatory and Precancerous Gastric Conditions
  84. Epigenetic silencing of miR-137 is a frequent event in gastric carcinogenesis
  85. Differential expression of microRNAs in preneoplastic gastric mucosa
  86. Helicobacter pylori: perspectives and time trends
  87. MicroRNA miR-J1-5p as a potential Biomarker for JC Virus Infection in the Gastrointestinal Tract
  88. Sa1877 Methylation of miR-137 Is a Frequent and Early Event in Gastric Carcinogenesis
  89. Mo1869 Inverse Correlation of H. pylori and Eosinophilic Esophagitis
  90. Gene Polymorphisms of Micrornas in Helicobacter pylori-Induced High Risk Atrophic Gastritis and Gastric Cancer
  91. Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis
  92. Molecular diagnostics in gastric cancer
  93. Gastric Epithelial Expression of IL-12 Cytokine Family in Helicobacter pylori Infection in Human: Is it Head or Tail of the Coin?
  94. Systematische Charakterisierung von miR-21 Expression in Magenmukosa
  95. Curcumin Modulates DNA Methylation in Colorectal Cancer Cells
  96. microRNA in Gastrointestinal Cancer
  97. Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family
  98. Feasibility of Fecal MicroRNAs as Novel Biomarkers for Pancreatic Cancer
  99. Boswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cells
  100. Macro-Role of MicroRNA in Gastric Cancer
  101. Colorectal Cancers with Microsatellite Instability Display Unique miRNA Profiles
  102. MicroRNA in Stuhl – neuartige Biomarker für Pankreaskarzinomen
  103. Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics
  104. Epigenetic Silencing of miR-137 Is an Early Event in Colorectal Carcinogenesis
  105. Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening
  106. 932 Fecal MicroRNAs: Novel Biomarkers for Colon Cancer Screening
  107. 678 Methylation of miRNA-137 is a Frequent and Early Event in Colorectal Cancer (CRC)
  108. M1182 Novel Evidence for Curcumin-Induced DNA Methylation Changes in Colon Cancer Cells
  109. Impact of endoscopy-based research on quality of life in healthy volunteers
  110. JC Virus Mediates Invasion and Migration in Colorectal Metastasis
  111. Low-dose aspirin has no impact on systemic level of serine protease inhibitors in healthy volunteers
  112. The effect of single-dose naproxen on eicosanoid formation in human gastroduodenal mucosa